Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Surveyor(trade mark) nuclease-based detection of p53 gene mutations in haematological malignancy.

Surveyor(trade mark) nuclease-based detection of p53 gene mutations in haematological malignancy. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Surveyor(trade mark) nuclease-based detection of p53 gene mutations in haematological malignancy. Abstract Text:

    noriaki mitaniNoriaki Mitani,yoshimasa niwaYoshimasa Niwa,yasuyuki okamotoYasuyuki Okamoto,noriaki mitaniNoriaki Mitani,yoshimasa niwaYoshimasa Niwa,yasuyuki okamotoYasuyuki Okamoto,

    BACKGROUND: Surveyor(trade mark) nuclease is a new single-strand-specific endonuclease that cleaves heteroduplex DNA at a base-mismatch site in both DNA strands. We applied this enzyme to detection of p53 gene mutations in haematological malignancy. METHODS: DNA fragments including exons 5 and 6, and those including exons 7 and 8, of the p53 gene, were amplified by polymerase chain reaction using DNA samples extracted from bone marrow aspirates. Denaturation followed by gradual annealing of the amplified fragments formed a heteroduplex with a base-mismatch if a mutation existed because the DNA samples contained wild-type DNA derived from coexisting non-malignant cells. After cleavage by Surveyor nuclease, mutations were simply detected by gel electrophoresis as extra bands of shorter size. RESULTS: Somatic mutations were clearly detected by this method in three of 39 different samples and confirmed by sequencing. The limit of detection estimated by changing the proportion of heteroduplexes in hetero/homoduplexes was between 1/8 and 1/16. CONCLUSION: We suggest that our method is not only simple, but also sensitive, compared with other complicated methods, and would therefore be useful in current clinical laboratory settings.

    Surveyor(trade mark) nuclease-based detection of p53 gene mutations in haematological malignancy. Publishing Authors By Initials

    n mitaniN Mitani,y niwaY Niwa,y okamotoY Okamoto,n mitaniN Mitani,y niwaY Niwa,y okamotoY Okamoto,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Surveyor(trade mark) nuclease-based detection of p53 gene mutations in haematological malignancy. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Annals of clinical biochemistry

    VOLUME: 44

    Page Numbers: 557-9

    Journal Abbreviation: Ann. Clin. Biochem.

    ISSN: 0004-5632

    DAY: 26

    MONTH: Nov

    YEAR: 2007

    Surveyor(trade mark) nuclease-based detection of p53 gene mutations in haematological malignancy. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 324055

    Surveyor(trade mark) nuclease-based detection of p53 gene mutations in haematological malignancy. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Surveyor(trade mark) nuclease-based detection of p53 gene mutations in haematological malignancy. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Surveyor(trade mark) nuclease-based detection of p53 gene mutations in haematological malignancy.

    AFFILIATION: Central Clinical Laboratory, Nara Medical University Hospital, Shijo-Cho 840, Kashihara, Nara 634-8522, Japan.

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Ann Clin Biochem

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Surveyortrade mark nuclease-based detection of p53 gene mutations in haematological malignancy Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News